Phase II Study of Panobinostat (LBH589) Given In Combination With Bortezomib (Velcade) In Patients With Pancreatic Cancer Progressing On Gemcitabine Therapy Alone Or Gemcitabine In Combination
|Effective start/end date||9/1/07 → 6/30/12|
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.